Furthermore, PEITC treatment resulted in the inhibition of the viability of ALDH-positive cells, decreased self-renewal ability, and inhibition of sphere formation efficiency in ovarian cancer (SKOV-3) and breast cancer cells (BT474, SKBR3, and HCC1954). This evidence concerns the gene LDHA and breast carcinoma.